{"id":"W3117939710","doi":"10.1016/j.pcad.2020.12.008","title":"How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors","year":2020,"lang":"en","type":"review","venue":"Progress in Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Sanofi","keywords":"Medicine; PCSK9; Adverse effect; Clinical trial; Secondary prevention; Intensive care medicine; Disease; Ldl cholesterol; Cholesterol; Drug; Epidemiology; Pharmacology; Internal medicine; LDL receptor; Lipoprotein","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004066342,0.000740308,0.006097878,0.0003618921,0.00006083422,0.0001038093,0.00049454,0.0006489055,0.00001008686],"category_scores_gemma":[0.0006048614,0.0005219602,0.005290329,0.001191188,0.0004547704,0.0001743126,0.0003152767,0.002326392,0.000002087537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000195382,"about_ca_system_score_gemma":0.001226782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005843388,"about_ca_topic_score_gemma":0.00004936839,"domain_scores_codex":[0.9912526,0.003257784,0.001958062,0.00132494,0.001604646,0.0006019748],"domain_scores_gemma":[0.9968339,0.0003454768,0.0004082718,0.001956072,0.00009659413,0.0003597015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001596577,0.0008234939,0.01076306,0.02808434,0.002944729,0.0007846801,0.0001273134,9.787886e-7,5.857638e-9,0.00000894919,0.00005567311,0.9562471],"study_design_scores_gemma":[0.008566238,0.0004373219,0.09332749,0.03054395,0.007707369,0.0002542323,0.0002466489,0.000005343085,7.053478e-7,0.00002588393,0.8582973,0.0005875094],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003666617,0.9876366,0.00001253546,0.0008121294,0.0002556106,0.007364586,0.0001554315,0.00004138632,0.00005514836],"genre_scores_gemma":[0.02808375,0.9695057,0.0001127344,0.000132729,0.0007636194,0.0009615987,0.0003216842,0.0001105502,0.000007594804],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9556596,"threshold_uncertainty_score":0.9999753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0597450074608118,"score_gpt":0.3738832317379662,"score_spread":0.3141382242771544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}